Topics

20172025 World Rosuvastatin Calcium Market Research Report by Product Type, EndUser / Application and Regions / Countries [Published by HeyReport] Prices from USD $2380

23:58 EST 2 Feb 2020 | BioPortfolio Reports

Summary


Rosuvastatin calcium CAS 147098202, molecular formula being C44H54CaF2N6O12S2 is the active pharmaceutical ingredient for the onceaday dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained depending on formulation.Rosuvastatin Calcium is a member of the drug class of statins, used in combination with exercise, diet, and weightloss to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Rosuvastatin Calcium was developed by Shionogi and has been formulated into finished oral dosage form and marketedby AstraZeneca as Crestor, Abbott Laboratories as R2.

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

The report includes as follows:

The report provides current data, historical overview and future forecast.

The report includes an indepth analysis of the Global market for Rosuvastatin Calcium , covering Global total and major region markets.

The data of 20172025 are included. Allinclusive market are given through data on sales, consumption, and prices Global total and by major regions.

The report provides introduction of leading Global manufacturers.

Rosuvastatin Calcium market prospects to 2025 are included in sales, consumption and price.

Market Segment as follows:

By Region / Countries

North America U.S., Canada, Mexico

Europe Germany, U.K., France, Italy, Russia, Spain etc

AsiaPacific China, India, Japan, Southeast Asia etc

South America Brazil, Argentina etc

Middle East Africa Saudi Arabia, South Africa etc

By Type

Purity 98.0%

Purity 99.0%

Others

By EndUser / Application

Tablet including dispersible tablet and general tablet

Capsule

Others

By Company

AstraZeneca

Teva Pharmaceutical Industries

MSN Laboratories

Cadila Pharmaceuticals

LGM Pharma

Bal Pharma

Changzhou Pharmaceutical Factory

Jingxin Pharm

Zhejiang Hisun Pharmaceutical

HEC Pharm

Lunan Pharmaceutical

Nanjing Frochem Tech

Lianyungang Runzhong Pharmaceutical

Shandong Bechem Chemicals

CTX Life Sciences

Original Article: 20172025 World Rosuvastatin Calcium Market Research Report by Product Type, EndUser / Application and Regions / Countries [Published by HeyReport] Prices from USD $2380

NEXT ARTICLE

More From BioPortfolio on "20172025 World Rosuvastatin Calcium Market Research Report by Product Type, EndUser / Application and Regions / Countries [Published by HeyReport] Prices from USD $2380"

Quick Search

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Statins
Statins (or HMG-CoA reductase inhibitors) are a class of drug used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. Increased cholesterol levels have been as...